药理学激活cGAS-STING通路以逆转癌症药物耐药性
Yumin Wang1, Yan Wang2, Qingzhu Gao3
1Department of Respiratory and Critical Care Medicine, Aerospace Center Hospital, Peking University Aerospace School of Clinical Medicine, Beijing 100049, China.
Pharmacology & therapeutics
|February 3, 2026
概括
癌细胞通过阻断干扰素基因 (STING) 循环GMP-AMP合成酶 (cGAS) -刺激器通路来发展耐药性. 重新激活cGAS-STING信号的小分子可以克服这种阻力,提供新的治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 分子生物学分子生物学
背景情况:
- 治疗耐药性是癌症治疗的一个重大障碍.
- 循环GMP-AMP合成酶 (cGAS) 刺激干扰素基因 (STING) 途径对于对细胞核DNA的先天免疫反应至关重要.
- 癌细胞通常通过抑制cGAS-STING通路来逃避治疗.
研究的目的:
- 审查癌细胞抑制cGAS-STING信号传递的机制.
- 评估重新激活cGAS-STING以克服治疗阻力的小分子激动剂.
- 通过准cGAS-STING通路,为扭转耐药性的新策略提供信息.
主要方法:
- 对分子和细胞发现的文献综述.
- 对表观遗传调节,后翻译性修饰 (PTMs) 和影响cGAS-STING的代谢变化的分析.
- 在临床前和临床环境中对cGAS-STING激动剂的研究的评估.
主要成果:
- 癌细胞使用表观遗传,PTM和代谢策略来抑制cGAS-STING.
- 对cGAS-STING信号的重新激活显示出恢复对各种癌症疗法的敏感性有希望.
- 小分子激动剂正在开发中,以向这些抵抗机制.
结论:
- 了解cGAS-STING抑制是开发抗药性治疗的关键.
- 对cGAS-STING的药理反应激活提供了一种可行的策略来对抗治疗耐药性.
- 本综述为未来针对瘤学中cGAS-STING途径的药物开发提供了洞察力.
更多相关视频
相关概念视频
Treatment Resistant Cancers
3.8K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.8K
Drug Abuse and Addiction: Pharmacological Phenomena
1.3K
Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
1.3K
Factors Influencing Drug Absorption: Disease States and Pharmacology
1.4K
Multiple disease states can significantly influence the oral drug absorption process by affecting blood flow and the functionality of the gastrointestinal (GI) system. Various GI diseases, including conditions that alter GI motility, such as diarrhea, decreased acid secretions (achlorhydria), and infections, have been associated with reduced drug absorption.
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
Substances such as alcohol and specific drugs, including antineoplastics, can also negatively impact drug absorption. For instance,...
1.4K
Antiepileptic Drugs: GABAergic Pathway Potentiators
1.3K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.3K
C4 Pathway and CAM
49.2K
Most plants use the C3 pathway for carbon fixation. However, some plants, such as sugar cane, corn, and cacti that grow in hot conditions, use alternative pathways to fix carbon and conserve energy loss due to photorespiration. Photorespiration is the process that occurs when the oxygen concentration is high. Under such conditions, the rubisco enzyme in the Calvin cycle binds O2 instead of CO2, which halts photosynthesis and consumes energy.
C4 Pathway
The C4 pathway is used by plants such as...
C4 Pathway
The C4 pathway is used by plants such as...
49.2K
Structure-Activity Relationships and Drug Design
1.8K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.8K


